Brightlands Venture Partners — 2017 Investments
3 investments dated 2017 · listed companies and verified rows first · show all
Kriya Materials develops nanoparticle-based coating systems and dispersions for optical applications, covering functions such as anti-reflection, anti-static, anti-fouling and hardcoats.
Advanced ManufacturingDeep TechNew MaterialsNuth, NL
Co-investorsSHIFT InvestChemelot VenturesHolland Capital
Takeda is a global pharmaceutical company that develops medicines and treatments for patients, focused on advancing science, technology, and partnerships to create new standards of care.
BiotechHealthtechTokyo, JP
Claudia D'Augusta(Executive Officer)inEduardo Bravo Fernandez de Araoz(Executive Officer, Director)Marie Paule Richard(Executive Officer)inWilfried Dalemans(Executive Officer)
BoardJune Almenoff(Director)Russell Greig(Director)
Co-investorsKleiner PerkinsRho VenturesRoche Venture FundYsios CapitalKreos Capital
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Health Value Creation
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.




